NMS-P715
CAS No. 1202055-32-0
NMS-P715 ( —— )
产品货号. M26336 CAS No. 1202055-32-0
NMS-P715 是一种高选择性和 ATP 竞争性 MPS1 抑制剂(IC50 为 182 nM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥641 | 有现货 |
|
| 5MG | ¥907 | 有现货 |
|
| 10MG | ¥1416 | 有现货 |
|
| 25MG | ¥2567 | 有现货 |
|
| 50MG | ¥3692 | 有现货 |
|
| 100MG | ¥5265 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NMS-P715
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NMS-P715 是一种高选择性和 ATP 竞争性 MPS1 抑制剂(IC50 为 182 nM)。
-
产品描述NMS-P715 is a highly selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).(In Vitro):NMS-P715 (1 μM) inhibits the proliferation of HCT116 cells. And it causes mitotic acceleration in U2OS cells overexpressing YFP-α-tubulin, induces aneuploidy. NMS-P715 (0.5, 1 μM) affects mitotic checkpoint complex (MCC) stability and cdc20 ubiquitylation. (In Vivo):NMS-P715 (90 mg/kg, p.o.) is well tolerated and causes no signs of body weight loss or other overt toxicities in an A2780 ovary carcinoma xenograft model.
-
体外实验NMS-P715 is a selective inhibitor of MPS1, with an IC50 of 182 nM. NMS-P715 is highly specific for MPS1, with no other kinases inhibited below an IC50 value of 5 μM and only 3 kinases inhibited below 10 μM (CK2, MELK, and NEK6). NMS-P715 promotes massive spindle assembly checkpoint (SAC) override with an EC50 of 65 nM. NMS-P715 (1 μM) causes mitotic acceleration in U2OS cells overexpressing YFP-α-tubulin, induces aneuploidy and inhibits the proliferation of HCT116 cells. NMS-P715 (0.5, 1 μM) affects mitotic checkpoint complex (MCC) stability and cdc20 ubiquitylation. NMS-P715 (1 μM) exhibits bypass of the spindle assembly checkpoint and apoptosis in pancreatic ductal adenocarcinoma (PDAC) cell lines. NMS-P715 (0-25 μM) also selectively inhibits growth of PDAC cells.
-
体内实验NMS-P715 (10 mg/kg) exhibits an oral bioavailability of 37% and good pharmacokinetic properties in nude mice bearing subcutaneous implanted human tumor cell xenografts. NMS-P715 (90 mg/kg, p.o.) is well tolerated and cuases no signs of body weight loss or other overt toxicities in an A2780 ovary carcinoma xenograft model. NMS-P715 (100 mg/kg, p.o.) inhibits the tumor growth by appr 43% in the A375 melanoma xenograft model.
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Casein Kinase
-
受体Protease
-
研究领域——
-
适应症——
化学信息
-
CAS Number1202055-32-0
-
分子量676.745
-
分子式C35H39F3N8O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 2 mg/mL (2.96 mM)
-
SMILESCCc1cccc(CC)c1NC(=O)c1nn(C)c-2c1CCc1cnc(Nc3ccc(cc3OC(F)(F)F)C(=O)NC3CCN(C)CC3)nc-21
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Timothy O'connell, et al. Enzyme stabilizers. WO2017220302A1.
021-51111890
购物车()
sales@molnova.cn

